Tapewire

Nasdaq · USD

GCTK

Glucotrack, Inc.

Export transactions ↓
Tapewire entity
8422
SEC CIK
0001506983
Parsed reports
51

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 08, 2017 Filed Mar 14, 2017 16:00 UTC PurchaseSeries C-2 Warrants · Derivative 222,223 Not disclosed Strike: $7.75 Not disclosed
Disclosure

SEC source: 0001178913-17-000765 · zk1719675.xml · derivative · entry 3

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 222,223

Underlying: Common Stock, par value $0.001 per share · 222,223 shares

Expires 2022-03-08

F6 · derivative.exercise_price: The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof).

F4 · price: The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
March 08, 2017 Filed Mar 14, 2017 16:00 UTC PurchaseSeries C-1 Warrants · Derivative 222,223 Not disclosed Strike: $4.50 Not disclosed
Disclosure

SEC source: 0001178913-17-000765 · zk1719675.xml · derivative · entry 2

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 222,223

Underlying: Common Stock, par value $0.001 per share · 222,223 shares

Expires 2022-03-08

F6 · derivative.exercise_price: The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof).

F4 · price: The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
March 08, 2017 Filed Mar 14, 2017 16:00 UTC PurchaseSeries C 5.5% Convertible Preferred Stock · Derivative 1,000 Not disclosed Strike: $4.50 Not disclosed
Disclosure

SEC source: 0001178913-17-000765 · zk1719675.xml · derivative · entry 1

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 1,000

Underlying: Common Stock, par value $0.001 per share · 222,223 shares

Expires not disclosed

F1 · derivative.exercise_price: Footnote 1 is attached hereto as Exhibit 99.1.

F4 · price: The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F2 · derivative.expiration_date: The Series C 5.5% Convertible Preferred Stock has no expiration date.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 13:00 UTC PurchaseSeries C-2 Warrants · Derivative 66,667 Not disclosed Strike: $7.75 Not disclosed
Disclosure

SEC source: 0001178913-16-007072 · zk1619271.xml · derivative · entry 3

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 66,667

Underlying: Common Stock, par value $0.001 per share · 66,667 shares

Expires 2021-11-30

F6 · derivative.exercise_price: The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof).

F4 · price: The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 13:00 UTC PurchaseSeries C-1 Warrants · Derivative 66,667 Not disclosed Strike: $4.50 Not disclosed
Disclosure

SEC source: 0001178913-16-007072 · zk1619271.xml · derivative · entry 2

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 66,667

Underlying: Common Stock, par value $0.001 per share · 66,667 shares

Expires 2021-11-30

F6 · derivative.exercise_price: The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof).

F4 · price: The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 13:00 UTC PurchaseSeries C 5.5% Convertible Preferred Stock · Derivative 300 Not disclosed Strike: $4.50 Not disclosed
Disclosure

SEC source: 0001178913-16-007072 · zk1619271.xml · derivative · entry 1

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vayikra Capital, LLC

Disclosed balance after: 300

Underlying: Common Stock, par value $0.001 per share · 66,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Footnote 1 is attached hereto as Exhibit 99.1.

F4 · price: The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share.

F2 · derivative.expiration_date: The Series C 5.5% Convertible Preferred Stock has no expiration date.

F3 · derivative.underlying_shares: The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person.

F5 · ownership.nature: The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 15, 2016 Filed Nov 15, 2016 17:51 UTC GrantOptions (Right to Buy) · Derivative 26,666 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001178913-16-006960 · zk1619216.xml · derivative · entry 1

SCHWARTZ REVAN · CIK 0001690043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,666

Underlying: Common Stock, par value $0.001 per share · 26,666 shares

Expires 2026-11-15

F1 · derivative.exercise_date: The options will vest in 8 equal quarterly installments with the first installment vesting on February 15, 2017 subject to the continued service of the Reporting Person as of each such date.

Read SEC document
November 15, 2016 Filed Nov 21, 2016 12:59 UTC GrantOptions (Right to Buy) · Derivative 26,666 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001178913-16-006995 · zk1619231.xml · derivative · entry 1

Darivoff Philip · CIK 0001690551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,666

Underlying: Common Stock, par value $0.001 per share · 26,666 shares

Expires 2026-11-15

F1 · derivative.exercise_date: The options will vest in 8 equal quarterly installments with the first installment vesting on February 15, 2017 subject to the continued service of the Reporting Person as of each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.